According to a research report “ Intracranial Pressure (Icp) Monitoring Devices Market” by Product (Invasive, Non-invasive) Application (Traumatic brain injury, Intracerebral hemorrhage, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 632.4 million, at a CAGR of 6.78% during the forecast period. Product launches serve as strategic initiatives for businesses to broaden their product portfolios and extend their market reach. In the global Intracranial Pressure (ICP) monitoring market, intense competition among vendors has led to an increase in the number and enhancement of offerings. Notably, in August 2020, IRRAS AB unveiled the first usage of its Hummingbird Solo ICP Monitoring System in Mexico. This single-lumen, bolt-based device, which measures brain tissue pressure, aids in diagnosing and managing patients with intracranial pressure issues following traumatic brain injury, subarachnoid hemorrhage, or stroke..
Browse market data tables, figures, and in-depth TOC on “Intracranial Pressure (Icp) Monitoring Devices Market” by Product (Invasive, Non-invasive) Application (Traumatic brain injury, Intracerebral hemorrhage, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Product, the Invasive segment is projected to dominate the market size in 2024
The Intracranial Pressure (ICP) monitoring devices market represents a significant business opportunity due to the increasing prevalence of neurological disorders and traumatic brain injuries. These devices enable healthcare professionals to assess and manage ICP, thereby improving patient outcomes and reducing morbidity and mortality. Key players in this market include Compamedics, Codman & Shurtleff, and Integra LifeSciences, who offer advanced technologies such as fiber optic sensors and micro-sensors to ensure accurate and reliable ICP measurement. The market is expected to grow steadily due to the rising demand for minimally invasive procedures and the increasing focus on patient-centric care.
By Application, Traumatic brain injury segment is expected to hold the largest market size for the year 2024
The Intracranial Pressure (ICP) monitoring devices market represents a significant business opportunity for healthcare technology innovators. These devices are essential tools for neurosurgeons and critical care specialists, enabling real-time assessment and management of ICP in brain injury and neurological disorders patients. Market growth is driven by rising incidence of neurological disorders, increasing number of minimally invasive procedures, and technological advancements in ICP monitoring systems. Companies focusing on developing user-friendly, cost-effective, and accurate ICP monitoring devices will gain a competitive edge in this market.
North America is forecasted to hold the largest market size by region in 2024
The Intracranial Pressure (ICP) monitoring devices market represents a significant business opportunity for healthcare technology innovators. These devices are essential for managing and treating various neurological conditions, including traumatic brain injury and hydrocephalus. Market growth is driven by the increasing prevalence of these conditions, advancements in technology, and the need for more accurate and reliable ICP measurement. Key players in this market include Medtronic, Integra LifeSciences, and Codman Neuro.
The Intracranial Pressure (Icp) Monitoring Devices Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Intracranial Pressure (ICP) Monitoring Devices Market encompasses a range of technologies used to measure and monitor the pressure within the skull, including Electroencephalography (EEG), Magnetic Resonance Imaging (MRI), data analytics, and artificial intelligence. ICP monitoring is essential for managing various neurological conditions such as strokes, idiopathic intracranial hypertension, and intracranial aneurysms. Continuous ICP monitoring is often achieved through invasive methods using a catheter and external pressure transducer, while non-invasive techniques such as otoacoustic emission and pupillometry are also gaining popularity. Neuromonitoring technologies, including MRI and EEG, provide valuable data for ICP assessment and therapy. ICP monitoring plays a crucial role in intracranial hypertension therapy, particularly for the geriatric population and those with traumatic brain injury. The pathophysiology of intracranial hypertension involves increased cerebrospinal fluid (CSF) pressure within the cranium, which can compress the brain parenchyma and cerebral ventricles. ICP monitoring devices are also finding applications in space medical applications. Advancements in technology, including data analytics and artificial intelligence, are enabling more accurate and timely ICP monitoring and response to drug administration. Non-invasive techniques, such as acoustic sound and ophthalmoscopy, offer promising alternatives to invasive methods. Overall, ICP monitoring devices are essential tools for neurospecialists in the diagnosis and management of various neurological conditions.
Market Research Overview
The Intracranial Pressure (ICP) Monitoring Devices Market encompasses a range of technologies used to measure and monitor intracranial pressure in neurological conditions such as strokes, idiopathic intracranial hypertension, and secondary brain damage. These devices employ data analytics and artificial intelligence to analyze cerebrospinal fluid dynamics, patient positioning, and real-time data for early detection and continuous surveillance. Non-invasive techniques like venous ophthalmodynamometry and transcranial Doppler ultrasonography are gaining popularity, while invasive methods like external ventricular drains and intraventricular catheters continue to be used for treatment and patient management. Robotic companies are developing surgical robots, neurosurgery devices, and neurodiagnostic solutions for ICP monitoring. Calibration techniques and 3D imaging are essential for accurate readings, while EEG, fundoscopy, and pupillometry provide additional diagnostic information. ICP monitoring devices are used in various healthcare settings, including ICUs, Neurology Centers, Trauma Centers, and Ambulatory Surgical Centers, for the treatment of conditions such as CNS infections, malignant cerebral infarction, cerebral edema, hydrocephalus, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury. Mispositioning, obstruction, malfunction, hemorrhage, and infection are common challenges in ICP monitoring. Continuous ICP monitoring, drug administration, and patient management require careful attention to detail and real-time data analysis to minimize these risks. ICP therapy includes intracranial hypertension therapy, pathophysiology, and ICU utilization. Neurological disorders like obesity, migraine, cerebral amyloid angiopathy, and intraparenchymal pressure monitor are also relevant to ICP monitoring. The geriatric population is a significant user group for ICP monitoring devices due to the higher prevalence of neurological disorders in this age group. Otoacoustic emission, brain parenchyma, cerebral ventricles, cranium diameter, and pupillometry are additional parameters used in ICP monitoring. In conclusion, ICP monitoring devices play a crucial role in the diagnosis and treatment of various neurological conditions. Continuous surveillance, early detection, and real-time data analysis are essential for effective patient management and minimizing secondary brain damage.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted